tiprankstipranks
Trending News
More News >
Aspen Aerogels (ASPN)
NYSE:ASPN

Aspen Aerogels (ASPN) AI Stock Analysis

Compare
1,236 Followers

Top Page

ASPN

Aspen Aerogels

(NYSE:ASPN)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 4o)
Rating:44Neutral
Price Target:
$3.00
▲(1.35% Upside)
Aspen Aerogels faces significant financial challenges, with strong revenue growth overshadowed by profitability and cash flow issues. Technical indicators suggest bearish momentum, and valuation metrics are unattractive due to ongoing losses. Despite these challenges, potential growth opportunities in new segments and improved liquidity provide some optimism.
Positive Factors
Strategic Leadership Changes
The introduction of experienced leaders can enhance operational efficiency and strategic execution, supporting long-term growth initiatives.
Energy Industrial Segment Growth
Growth in the Energy Industrial segment indicates a positive trajectory, potentially offsetting challenges in other areas and driving future revenue.
Amended Credit Facility
Improved liquidity and covenant flexibility strengthen Aspen's financial position, supporting execution of its growth strategy into 2026.
Negative Factors
Profitability Challenges
Ongoing profitability issues, reflected in negative margins, can hinder long-term sustainability and limit reinvestment opportunities.
Decline in Revenue
A decline in revenue, particularly in key markets, may signal weakening demand and impact future growth prospects.
Uncertain EV Market Conditions
Uncertainty in the EV market could lead to reduced demand for Aspen's products, affecting revenue and strategic positioning.

Aspen Aerogels (ASPN) vs. SPDR S&P 500 ETF (SPY)

Aspen Aerogels Business Overview & Revenue Model

Company DescriptionAspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.
How the Company Makes MoneyAspen Aerogels primarily generates revenue through the sale of its aerogel insulation products, which are utilized in high-performance applications in industries such as oil and gas, where they help reduce energy costs and improve operational efficiency. Key revenue streams include direct sales to large industrial clients, partnerships with engineering and construction firms, and collaborations with manufacturers in sectors like building materials. The company may also benefit from government incentives related to energy efficiency and sustainability initiatives. Additionally, Aspen Aerogels focuses on expanding its market presence through strategic partnerships and collaborations, which can enhance its product offerings and access to new customer segments.

Aspen Aerogels Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down revenue across different regions, revealing where the company is strongest and where it may face risk or growth potential due to local economic conditions or market share shifts.
Chart InsightsAspen Aerogels is experiencing robust revenue growth in the United States and Latin America, driven by strategic initiatives like the GM PyroThin award and supply chain diversification. However, Asia's revenue is declining, possibly due to market saturation or competitive pressures. Despite a 17% year-over-year revenue decline, the company is focusing on cost optimization and new OEM opportunities, setting the stage for potential long-term growth. The earnings call highlights strategic achievements but also underscores immediate financial challenges, such as declining gross margins and net income losses.
Data provided by:The Fly

Aspen Aerogels Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 12, 2026
Earnings Call Sentiment Neutral
The earnings call reflects a challenging quarter for Aspen Aerogels, with declining revenue and profitability primarily due to EV market uncertainties. However, positive developments in leadership, potential growth in the European market, and emerging opportunities in energy industrial and storage systems provide some optimism for future growth.
Q3-2025 Updates
Positive Updates
Introduction of New Leadership
Aspen Aerogels introduced two key additions to its leadership team: Grant Thoele as CFO and Glenn Deegan as Chief Administrative Officer, bringing significant operational, transactional, and integration experience.
Design Award from European OEM
Aspen won a battery design award from a major European OEM, expected to ramp in 2027, demonstrating potential growth in the European market.
Energy Industrial Segment Growth
The Energy Industrial segment is stabilizing and expected to grow in 2026 with substantial subsea project revenue and a return to robust sales, indicating a positive trajectory.
Battery Energy Storage Systems Opportunity
Shifting to higher-density LFP designs in grid-scale storage presents a new opportunity for Aspen's PyroThin thermal barrier technology, with potential contributions to revenue in 2026.
Negative Updates
Decline in Q3 Revenue and Gross Profit
Q3 revenue declined by 6% to $73 million, and gross profit decreased by 18% due to lower EV volumes and less volume to absorb fixed costs.
Uncertain EV Market Conditions
GM and other OEMs are recalibrating production due to market demand, leading to significant uncertainty and a downward revision of Aspen's outlook for Q4 2025.
Negative Adjusted EBITDA Expected in Q4
Aspen projects Q4 adjusted EBITDA to range between negative $14 million to negative $6 million due to regulatory changes affecting EV production.
Financial Challenges and Covenant Relief
Aspen is engaging with lenders for covenant relief due to lower expected full-year results and impacts on liquidity, highlighting financial challenges.
Company Guidance
During Aspen Aerogels' Q3 2025 earnings call, management provided guidance for Q4 and the fiscal year, highlighting several key metrics. They projected Q4 revenue between $40 million to $50 million, with an anticipated mix of approximately $25 million from the Energy Industrial segment. Fiscal year 2025 revenue was expected to range from $270 million to $280 million, with adjusted EBITDA between $7 million to $15 million. The company noted a decline in Q3 revenue to $73 million, down 6% from the previous quarter, with a gross margin decrease to 28.5% from 32.4%. They also highlighted a focus on streamlining operations to achieve adjusted EBITDA breakeven at approximately $200 million in annual revenue. Looking forward, Aspen anticipates a strong growth year in 2026 for the Energy Industrial segment, with potential subsea project revenue of $15 million to $20 million and a supply agreement for the Venture Global CP2 LNG project. Additionally, Aspen is targeting new opportunities in battery energy storage systems, which could contribute significantly to 2026 revenues.

Aspen Aerogels Financial Statement Overview

Summary
Aspen Aerogels demonstrates strong revenue growth but faces significant challenges in profitability and cash flow management. The balance sheet is stable, yet negative returns on equity and cash flow issues pose risks to long-term sustainability.
Income Statement
45
Neutral
Aspen Aerogels shows significant revenue growth in the TTM period, with a remarkable increase of over 18,000%. However, profitability remains a challenge, as indicated by negative net profit and EBIT margins. The gross profit margin has improved compared to previous years, but the company still struggles with negative EBITDA and EBIT margins, reflecting operational inefficiencies.
Balance Sheet
55
Neutral
The company's balance sheet shows a moderate debt-to-equity ratio, indicating a balanced approach to leveraging. However, the return on equity is negative, suggesting that the company is not generating sufficient returns on its equity base. The equity ratio is stable, but the negative ROE highlights profitability concerns.
Cash Flow
40
Negative
Aspen Aerogels faces challenges in cash flow management, with negative free cash flow growth and low operating cash flow coverage. The operating cash flow to net income ratio is extremely low, indicating cash flow issues. Despite a slight improvement in free cash flow to net income ratio, the overall cash flow position remains weak.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue352.85M452.70M238.72M180.36M121.62M100.27M
Gross Profit116.06M182.90M56.92M4.98M9.94M14.59M
EBITDA-269.00M51.46M-22.31M-68.41M-27.43M-11.37M
Net Income-305.28M13.38M-45.81M-82.74M-37.09M-21.81M
Balance Sheet
Total Assets491.39M895.14M703.05M643.42M182.95M97.42M
Cash, Cash Equivalents and Short-Term Investments150.72M220.88M139.72M281.33M76.56M16.50M
Total Debt150.16M197.38M138.77M119.40M15.24M8.31M
Total Liabilities185.66M280.44M214.99M195.98M54.55M29.57M
Stockholders Equity305.73M614.71M488.06M447.44M128.41M67.85M
Cash Flow
Free Cash Flow2.69M-40.71M-218.07M-272.37M-32.41M-13.34M
Operating Cash Flow52.42M45.55M-42.61M-94.40M-18.63M-9.92M
Investing Cash Flow-49.74M-86.26M-175.46M-177.97M-13.78M-3.42M
Financing Cash Flow35.86M122.02M75.48M478.37M92.47M26.20M

Aspen Aerogels Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.96
Price Trends
50DMA
5.08
Negative
100DMA
6.12
Negative
200DMA
6.20
Negative
Market Momentum
MACD
-0.47
Negative
RSI
30.55
Neutral
STOCH
7.95
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASPN, the sentiment is Negative. The current price of 2.96 is below the 20-day moving average (MA) of 3.24, below the 50-day MA of 5.08, and below the 200-day MA of 6.20, indicating a bearish trend. The MACD of -0.47 indicates Negative momentum. The RSI at 30.55 is Neutral, neither overbought nor oversold. The STOCH value of 7.95 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ASPN.

Aspen Aerogels Risk Analysis

Aspen Aerogels disclosed 72 risk factors in its most recent earnings report. Aspen Aerogels reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Aspen Aerogels Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$260.95M18.8917.68%30.74%-13.58%
66
Neutral
$493.69M36.692.20%-0.19%-50.51%
64
Neutral
$834.41M19.008.83%2.68%1.19%-56.98%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
60
Neutral
$1.48B674.8613.29%-9.21%-97.43%
54
Neutral
$705.22M-28.88%2.07%43.81%-584.11%
44
Neutral
$244.64M-0.80-75.06%-14.74%-20086.56%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ASPN
Aspen Aerogels
2.96
-9.09
-75.44%
APOG
Apogee
38.79
-30.73
-44.20%
BXC
Bluelinx Holdings
62.77
-42.94
-40.62%
ROCK
Gibraltar Industries
49.94
-10.33
-17.14%
PPIH
Perma-Pipe International Holdings
32.24
17.74
122.34%
NX
Quanex
15.44
-9.14
-37.18%

Aspen Aerogels Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Aspen Aerogels Amends Credit Facility to Enhance Liquidity
Positive
Dec 18, 2025

On December 16, 2025, Aspen Aerogels and its affiliates amended their existing MidCap credit facility, raising the minimum liquidity threshold tied to the term loan balance, eliminating the minimum EBITDA covenant, revising mandatory prepayment terms to apply asset-sale proceeds to reduce amortization in order of maturity, and lowering the basket for permitted acquisitions. In a December 17, 2025 announcement, the company said the changes strengthen its financial position and provide added covenant flexibility, reflecting a liquidity outlook that is running ahead of expectations due to operational efficiencies, working-capital improvements and disciplined capital spending, which together should support execution of its growth strategy into 2026 and may reassure lenders and investors about its balance-sheet resiliency.

Business Operations and StrategyFinancial Disclosures
Aspen Aerogels Reports Q3 2025 Revenue Decline
Negative
Nov 6, 2025

Aspen Aerogels reported a decrease in total revenue to $73.0 million for Q3 2025, down from $117.3 million in Q3 2024, alongside a reduced net loss of $6.3 million compared to $13.0 million the previous year. The company updated its 2025 outlook to reflect lower demand in the U.S. EV market, while highlighting growth opportunities in its Energy Industrial segment for 2026 and a significant PyroThin® contract with a European OEM. Aspen is focusing on cost reduction and operational efficiency to stabilize and grow its business amid market challenges.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025